Subscribe
13 November 2025NewsAmericasMarisa Woutersen

‘I need them and they need me’: Regeneron counsel on what makes a strong law firm partnership

Regeneron’s Adam Gastonguay shares how to raise the profile of your IP team, get the most from outside counsel, and stay ahead of the growing pressure to adopt AI.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Unified Patent Court
Regeneron and CureVac: UPC ‘cannot be ignored’
4 November 2025   Growing clout, powerful remedies, and efficiency are making the UPC a game-changer in global litigation, according to LSPN Europe experts. Tom Phillips reports.
Americas
Regeneron hits Amgen over its blockbuster eye disease treatment
19 June 2025   The biotech firm strikes again over Eylea after Amgen launches biosimilar | Regeneron claims Amgen infringed agreed ‘patent dance’ | Follows other lawsuits aimed at protecting Eylea.
Americas
Regeneron edges closer to Eylea market exclusivity amid biosimilar threats
6 March 2025   New York biotech scores win as Fed Circ upholds preliminary injunction against Celltrion's biosimilar launch | Ruling follows intense scrutiny during Federal Circuit oral arguments | Decision follows similar rulings against Samsung Bioepis and Formycon.


Editor's picks

WIPR Rankings reveals the go-to firms and attorneys for China patent work
Asia
WIPR Rankings reveals the go-to firms and attorneys for China patent work
7 November 2025

Editor's picks

Asia
WIPR Rankings reveals the go-to firms and attorneys for China patent work
7 November 2025
Unified Patent Court
Regeneron and CureVac: UPC ‘cannot be ignored’
4 November 2025
Americas
Squires: ‘Inherited patent backlog was an absolute dumpster fire’
1 November 2025
Americas
Why AI is changing the patent rules faster than anyone can keep up
24 October 2025
Americas
LSPN panel unpacks critical IP risks in deal-making
23 October 2025
Americas
A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
23 October 2025

More features

7 in-house counsel tips for partnering with AI vendors
Patent applications for bio-cosmetics double in five years
Sun Pharma and BMS lead 2025 ANDA litigation
Weil continues IP expansion as another litigator jumps from rival firm
WIPR Rankings reveals the go-to firms and attorneys for China patent work
Pfizer can’t block Novo Nordisk’s $10bn takeover deal
WBD adds litigation firepower in Silicon Valley with DLA Piper veteran
New AIPLA president calls for greater certainty in US patent law